PMID- 30955263 OWN - NLM STAT- MEDLINE DCOM- 20190411 LR - 20211204 IS - 0529-5807 (Print) IS - 0529-5807 (Linking) VI - 48 IP - 4 DP - 2019 Apr 8 TI - [Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases]. PG - 282-287 LID - 10.3760/cma.j.issn.0529-5807.2019.04.004 [doi] AB - Objective: To investigate the clinicopathological features, diagnosis and differential diagnosis of dedifferentiated liposarcoma (DDLPS) with inflammatory myofibroblastic tumor (IMT)-like features. Methods: Five cases of DDLPS with IMT-like features were collected from the First Affiliated Hospital of Nanjing Medical University, the Affiliated Hospital of Nanjing University of Traditional Chinese Medicine and the First People's Hospital of Qinzhou between 2013 and 2018. EnVision method and fluorescence in situ hybridization (FISH) were used to detect the immunophenotype of the tumor cells and the profile of MDM2 gene amplification respectively. Results: All five cases were male and the median age was 61 (range 53 to 65) years. The clinical symptoms were mainly related to the space-occupying lesions. The tumors were located in duodenal mesentery (two cases), intestinal wall (one case), retroperitoneum (one case), and spermatic cord (one case). Grossly, the tumors were not well encapsulated, ranging from 3 to 13 cm (median 6.7 cm) in diameter, with tan to gray and firm cut surface. Histologically, the dedifferentiated component closely resembled inflammatory myofibroblastic tumor (IMT), with spindle/polygonal/stellate-shaped cells arranged in storiform, sheet-like, or random pattern, with varying degrees of chronic inflammation and fibrosis. All three major patterns seen in IMT (myxoid, cellular and hypocellular fibrous) were observed, the hypocellular fibrous pattern was the most common. Well-differentiated liposarcomatous component was found in the peripheral areas of all the tumors. One case had high grade dedifferentiated component. Four cases were strongly positive for MDM2 and p16. Two cases were positive for SMA, and one case was focally positive for desmin and one for CD34. None of the cases stained for ALK-1. FISH demonstrated MDM2 gene amplification in all five cases. Clinical follow-ups were available in all five cases and the interval ranged from 3 to 66 months (median 23 months). Two patients developed recurrences and one patient had metastasis. The remaining two patients were alive with no evidence of tumor recurrence at 3 and 14 months after surgery respectively. Conclusions: DDLPS with IMT-like features is a more aggressive neoplasm than its histological mimic (IMT), and should not be misdiagnosed as other intermediate or low-grade malignant tumors, such as IMT, sclerosing liposarcoma, inflammatory liposarcoma, aggressive fibromatosis, solitary fibrous tumors, low-grade myofibroblastic sarcoma, and low-grade fibrosarcoma. FAU - Si, H P AU - Si HP AD - Department of Pathology, the Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing 210029, China. FAU - Wang, Z AU - Wang Z AD - Department of Pathology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. FAU - Fan, Q H AU - Fan QH AD - Department of Pathology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. FAU - Zhang, Y F AU - Zhang YF AD - Department of Pathology, the Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing 210029, China. FAU - Yang, D Q AU - Yang DQ AD - Department of Pathology, the First People's Hospital of Qinzhou, Guangxi Autonomous Region, Qinzhou 535000, China. FAU - Zhang, Z H AU - Zhang ZH AD - Department of Pathology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. FAU - Gong, Q X AU - Gong QX AD - Department of Pathology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. LA - chi PT - Journal Article PL - China TA - Zhonghua Bing Li Xue Za Zhi JT - Zhonghua bing li xue za zhi = Chinese journal of pathology JID - 0005331 RN - 0 (CDKN2A protein, human) RN - 0 (Cyclin-Dependent Kinase Inhibitor p16) RN - 0 (MAS1 protein, human) RN - 0 (Proto-Oncogene Mas) RN - EC 2.3.2.27 (MDM2 protein, human) RN - EC 2.3.2.27 (Proto-Oncogene Proteins c-mdm2) SB - IM MH - Aged MH - Cyclin-Dependent Kinase Inhibitor p16/analysis/genetics MH - Diagnosis, Differential MH - Duodenal Neoplasms/genetics/*pathology MH - Fibrosarcoma/genetics/*pathology MH - Gene Amplification MH - Genital Neoplasms, Male/genetics/*pathology MH - Humans MH - Immunophenotyping MH - In Situ Hybridization, Fluorescence MH - Intestinal Neoplasms/genetics/*pathology MH - Liposarcoma/genetics/*pathology MH - Male MH - Middle Aged MH - Neoplasm Recurrence, Local MH - Proto-Oncogene Mas MH - Proto-Oncogene Proteins c-mdm2/genetics MH - Retroperitoneal Neoplasms/genetics/*pathology MH - Tumor Burden OTO - NOTNLM OT - Cell dedifferentiation OT - Inflammatory myofibroblastic tumor OT - Liposarcoma OT - Proto-oncogene proteins c-mdm2 OT - Soft tissue neoplasms EDAT- 2019/04/09 06:00 MHDA- 2019/04/12 06:00 CRDT- 2019/04/08 06:00 PHST- 2019/04/08 06:00 [entrez] PHST- 2019/04/09 06:00 [pubmed] PHST- 2019/04/12 06:00 [medline] AID - 10.3760/cma.j.issn.0529-5807.2019.04.004 [doi] PST - ppublish SO - Zhonghua Bing Li Xue Za Zhi. 2019 Apr 8;48(4):282-287. doi: 10.3760/cma.j.issn.0529-5807.2019.04.004.